Paroxysmal Sympathetic Hyperactivity







  • A.

    Paroxysmal sympathetic hyperactivity (PSH) is a syndrome encountered in patients with severe acute neurologic injury. Patients with PSH may have episodic tachycardia, hypertension, tachypnea, fever, diaphoresis, and posturing. Episodes may last minutes to hours and recur several times per day. Features supporting the diagnosis include multiple autonomic symptoms occurring simultaneously, multiple recurrent episodes over several days, and response to specific abortive therapy. The triggering of paroxysms by both noxious and non-noxious stimuli is also an important defining feature of PSH. The pathophysiology of the condition is poorly understood, but impaired descending inhibitory control of excitatory spinal circuits, permitting unregulated sympathetic outflow, is a commonly proposed mechanism. PSH is often seen in severe traumatic brain injury, but may occur with any type of acute brain injury. Historically, terms used to describe this condition include “dysautonomia,” “diencephalic seizures,” “sympathetic storming,” and “paroxysmal autonomic instability with dystonia.” Numerous medications are used to treat PSH, but there is little strong evidence to guide therapy. The most common agents employed in clinical practice are listed in Table 61.1 . Often a combination of agents is necessary to achieve control of PSH episodes.



    Table 61.1

    Dosing and titration of medications for paroxysmal sympathetic hyperactivity
































    Acute abortive therapies
    Starting dose Titration Maximum dose
    Morphine IV 2–4 mg IV q1–2 h prn 2-mg increments Doses up to 10 mg IV may be needed
    Propranolol IV 1–3 mg IV q1–2 h prn 1–2-mg increments 5 mg IV per dose
    Labetalol IV 10–20 mg IV q1–2 h prn 10-mg increments 80 mg IV per dose
    Midazolam IV 1–2 mg IV q2–4 h prn 1–2-mg increments 10 mg IV per dose















































    Maintenance/preventative therapies
    Oxycodone PO 5–10 mg q4–6 h 5-mg increments
    β-blockers
    Propranolol PO

    Labetalol PO

    10–20 mg q8–12 h
    100–200 mg q8–12 h

    10–20-mg increments
    100–200-mg increments

    320 mg/day a

    2400 mg/day a
    Clonidine PO 0.1 mg q8–12 h 0.1–0.2-mg increments 2.4 mg/day a
    Gabapentin PO 100–300 mg q8 h 200–300-mg increments 3600 mg/day a
    Benzodiazepines
    Clonazepam PO

    Diazepam PO

    0.25–1 mg q12 h
    2.5–10 mg q8–12 h

    0.5-mg increments

    5 mg increments



    Bromocriptine PO 1.25–2.5 mg q8–12h 2.5-mg increments 40 mg/day (divided q8–12 h)
    Baclofen PO 5 mg q8 h 5 mg/dose every 2–3 days 80 mg/day a
    Dantrolene PO 25 mg daily After 7 days increase to 25 mg tid. Titrate dose by 25–50 mg increments weekly. 400 mg/day (divided q6 h)

    Only gold members can continue reading. Log In or Register to continue

    Stay updated, free articles. Join our Telegram channel

May 3, 2021 | Posted by in NEUROLOGY | Comments Off on Paroxysmal Sympathetic Hyperactivity

Full access? Get Clinical Tree

Get Clinical Tree app for offline access